Literature DB >> 24861247

Imaging for the evaluation of endometriosis and adenomyosis.

Caterina Exacoustos1, Lucia Manganaro2, Errico Zupi3.   

Abstract

Endometriosis affects between 5 and 45% of women in reproductive age, is associated with significant morbidity, and constitutes a major public health concern. The correct diagnosis is fundamental in defining the best treatment strategy for endometriosis. Therefore, non-invasive methods are required to obtain accurate diagnoses of the location and extent of endometriotic lesions. Transvaginal sonography and magnetic resonance imaging are used most frequently to identify and characterise lesions in endometriosis. Subjective impression by an experienced sonologist for identifying endometriomas by ultrasound showed a high accuracy. Adhesions can be evaluated by real-time dynamic transvaginal sonography, using the sliding sign technique, to determine whether the uterus and ovaries glide freely over the posterior and anterior organs and tissues. Diagnosis is difficult when ovarian endometriomas are absent and endometriosis causes adhesions and deep infiltrating nodules in the pelvic organs. Magnetic resonance imaging seems to be useful in diagnosing all locations of endometriosis, and its diagnostic accuracy is similar to those obtained using ultrasound. Transvaginal ultrasound has been proposed as first line-line imaging technique because it is well accepted and widely available. The main limitation of ultrasound concerns lesions located above the rectosigmoid junction owing to the limited field-of-view of the transvaginal approach and low accuracy in detecting upper bowel lesions by transabdominal ultrasound. A detailed non-invasive diagnosis of the extension in the pelvis of endometriosis can facilitate the choice of a safe and adequate surgical or medical treatment.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adenomyosis; deep infiltrating endometriosis; endometrioma; junctional zone; pelvic adhesions; pouch of Douglas obliteration

Mesh:

Year:  2014        PMID: 24861247     DOI: 10.1016/j.bpobgyn.2014.04.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  33 in total

1.  Shining light in a dark landscape: MRI evaluation of unusual localization of endometriosis.

Authors:  Benedetta Gui; Anna Lia Valentini; Valeria Ninivaggi; Maura Miccò; Viola Zecchi; Pier Paolo Grimaldi; Francesco Cambi; Maurizio Guido; Lorenzo Bonomo
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

2.  Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway.

Authors:  Li Liu; Li Chen; Caixia Jiang; Jing Guo; Yan Xie; Le Kang; Zhongping Cheng
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

3.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

Review 4.  Laser vaporization compared with other surgical techniques in women with ovarian endometrioma: a systematic review and meta-analysis.

Authors:  Leila Adamyan; Victoria Kasyan; Laura Pivazyan; Sapiyat Isaeva; Julietta Avetisyan
Journal:  Arch Gynecol Obstet       Date:  2022-09-29       Impact factor: 2.493

5.  Research Priorities for Endometriosis.

Authors:  Peter A W Rogers; G David Adamson; Moamar Al-Jefout; Christian M Becker; Thomas M D'Hooghe; Gerard A J Dunselman; Asgerally Fazleabas; Linda C Giudice; Andrew W Horne; M Louise Hull; Lone Hummelshoj; Stacey A Missmer; Grant W Montgomery; Pamela Stratton; Robert N Taylor; Luk Rombauts; Philippa T Saunders; Katy Vincent; Krina T Zondervan
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

6.  Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.

Authors:  S Caruso; M Iraci; S Cianci; E Casella; V Fava; A Cianci
Journal:  J Endocrinol Invest       Date:  2015-09-04       Impact factor: 4.256

7.  Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.

Authors:  Rui Zheng; Dan Zeng; Ting-Ting Wan; Wen-Bo Guo; Yan Guo; Ming-Juan Liu
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

Review 8.  An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.

Authors:  Ivan Urits; Leena Adamian; Paulo Miro; Jessica Callan; Parth M Patel; Megha Patel; Amnon A Berger; Hisham Kassem; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15

9.  A Detailed Study in Adenomyosis and Endometriosis: Evaluation of the Rate of Coexistence Between Uterine Adenomyosis and DIE According to Imaging and Histopathology Findings.

Authors:  Saeed Alborzi; Elham Askary; Farideh Khorami; Tahereh Poordast; Batool Abdulwahid Hashim Alkhalidi; Mahboobeh Hamedi; Soroush Alborzi; Hadi Raeisi Shahraki
Journal:  Reprod Sci       Date:  2021-03-16       Impact factor: 3.060

10.  Sonographic Signs of Adenomyosis in Women with Endometriosis Are Associated with Infertility.

Authors:  Dean Decter; Nissim Arbib; Hila Markovitz; Daniel S Seidman; Vered H Eisenberg
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.